Genomic Valley Biotech Limited - life sciences in Jhajjar, Haryana, India. FY 2026 financials and compliance.
CIN L01122HR1994PLC033029 Incorporated 16 May 1994 ROC Haryana HQ Jhajjar, Haryana, India
Active Listed - BSE: 539206 Public Limited Company life sciences
Data last updated
Revenue · FY 2026
₹26.75 Lakh
▼ 68.3% YoY
Computed EBITDA · FY 2026
₹4.37 Lakh
▼ 90.16% YoY
Net profit · FY 2026
₹3.03 Lakh
▼ 91.49% YoY
Authorised capital
₹9 Cr
Registered with MCA
Paid-up capital
₹3.05 Cr
Issued & subscribed
Open charges
None
Satisfied ₹3.74 Cr
Company age
32 yrs
Est. 1994
Last financials
Mar 2025
Balance sheet date

About Genomic Valley Biotech Limited

Data last updated: 14 July 2026

Genomic Valley Biotech Limited is a public limited company based in Jhajjar, Haryana, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 16 May 1994, the company has been in operation for over 32 years.

Registered with ROC Haryana under CIN L01122HR1996PLC033029. Listed on BSE: 539206.

Capital: an authorised share capital of ₹9 Cr and a paid-up capital of ₹3.05 Cr. It is led by directors including Parul Agrawal and Yogesh Agrawal.

Last AGM: 31 December 2025. Financial statements filed for year ended 31 March 2025. Office: 4 K.M.Stone Berri Chharra Road Vill. Kherka Musalman P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, India – 124507.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹26.75 Lakh, a decline of 68.3% compared to the previous year. The net worth stands at ₹3.93 Cr (up 0.78% YoY). Total assets are valued at ₹4.25 Cr (down 2.46% YoY).

The company is associated with 1 brand - Genomic Valley Biotech. As per MCA filings, the company has satisfied charges of ₹3.74 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomicvalley.com.

Company Details of Genomic Valley Biotech Limited
CIN L01122HR1994PLC033029
Registration Number 033029
Incorporation Date 16 May 1994
ROC Haryana
Listing Status Listed (BSE: 539206)
Company Status Active
Date of Last AGM 31 December 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    4 K.M.Stone Berri Chharra Road Vill. Kherka Musalman P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, India – 124507
  • Industry
    Life Sciences, Biotechnology
Company report
Genomic Valley Biotech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Genomic Valley Biotech Limited report

Financials, compliance, directors, charges, ownership and filings for Genomic Valley Biotech Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Genomic Valley Biotech Limited

Genomic Valley Biotech Limited has one previous CIN (Corporate Identification Number): L01122HR1996PLC033029. The current CIN is L01122HR1994PLC033029, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L01122HR1994PLC033029 Current
L01122HR1996PLC033029 Previous

Associated Brands with Genomic Valley Biotech Limited

Genomic Valley Biotech Limited operates one associated brand: Genomic Valley Biotech. These brands represent Genomic Valley Biotech Limited's diversified market presence and brand portfolio.

Brand Description Website
R&D company focused on plant tissue cultured plants genomicvalley.com

Business Activity of Genomic Valley Biotech Limited

Genomic Valley Biotech Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including support activities to agriculture and other activities including hunting.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
A Agriculture, forestry, fishing A4 Support activities to agriculture and Other Activities including hunting Locked
Premium access

Business activity turnover details for Genomic Valley Biotech Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Genomic Valley Biotech Limited

Genomic Valley Biotech Limited is audited by ANDROS & CO. (ICAI peer reviewed, certificate valid till 2027-12-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
ANDROS & CO. (ICAI peer reviewed, certificate valid till 2027-12-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Genomic Valley Biotech Limited

Genomic Valley Biotech Limited is currently managed by 5 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Parul Agrawal Director 14 Feb 2024 2 Years 5 Months Current
Yogesh Agrawal Managing Director 07 Sep 2015 10 Years 10 Months Current
Satendra Kumar Goyal Director 09 May 2024 2 Years 2 Months Current
Yogainder Kumar Gupta Director 30 May 2025 1 Years 1 Months Current
Ashok Kumar Additional Director 14 Nov 2023 2 Years 8 Months Current

Financials of Genomic Valley Biotech Limited FY 2026 filings available

Genomic Valley Biotech Limited reported revenue of ₹26.75 Lakh (down 68.3% YoY) for FY 2026.

Revenue · FY 2026
₹26.75 Lakh ▼ 68.3%
Profit · FY 2026
₹3.03 Lakh ▼ 91.49%
Computed EBITDA · FY 2026
₹4.37 Lakh ▼ 90.16%
Revenue₹ Cr · Standalone0123FY 2019: ₹1 Cr1FY 2019FY 2020: ₹1 Cr · -14.1% YoY0.8-14.1%FY 2020FY 2021: ₹0 Cr · -75.4% YoY0.2-75.4%FY 2021FY 2022: ₹0 Cr · -66.1% YoY0.1-66.1%FY 2022FY 2023: ₹3 Cr · +3758.4% YoY2.7+3758.4%FY 2023FY 2024: ₹0 Cr · -93.9% YoY0.2-93.9%FY 2024FY 2025: ₹1 Cr · +411.2% YoY0.8+411.2%FY 2025FY 2026: ₹0 Cr · -68.3% YoY0.3-68.3%FY 2026
Net Profit₹ Cr · Standalone-0.8-0.5-0.300.30.50.8FY 2019: ₹0 Cr0.2FY 2019FY 2020: ₹0 Cr · +23% YoY0.3+23%FY 2020FY 2021: ₹1 Cr (loss) · -295.5% YoY-0.6FY 2021FY 2022: ₹0 Cr (loss) · +98.3% YoY-0FY 2022FY 2023: ₹1 Cr · +7040.7% YoY0.6+7040.7%FY 2023FY 2024: ₹0 Cr · -97.7% YoY0-97.7%FY 2024FY 2025: ₹0 Cr · +2245.8% YoY0.4+2245.8%FY 2025FY 2026: ₹0 Cr · -91.5% YoY0-91.5%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year00.10.20.3Q1'25: ₹0 Cr0.2Q1'25Q2'25: ₹0 Cr0.2Q2'25Q3'25: ₹0 Cr0.2Q3'25Q4'25: ₹0 Cr0.3Q4'25Q1'26: ₹0 Cr · -42.1% YoY0.1-42.1%Q1'26Q2'26: ₹0 Cr · -56.1% YoY0.1-56.1%Q2'26Q3'26: ₹0 Cr · -77.3% YoY0.1-77.3%Q3'26Q4'26: ₹0 Cr · -85.8% YoY0-85.8%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹26.75 Lakh ₹84.39 Lakh ₹16.51 Lakh ₹2.72 Cr ₹7.06 Lakh ₹20.81 Lakh ₹84.66 Lakh ₹98.5 Lakh
Other Income ₹0 ₹45,000 ₹15,000 ₹4.26 Lakh ₹8.4 Lakh ₹29,000 ₹1.41 Lakh ₹1.48 Lakh
Total Income ₹26.75 Lakh ₹84.84 Lakh ₹16.66 Lakh ₹2.77 Cr ₹15.46 Lakh ₹21.1 Lakh ₹86.07 Lakh ₹99.98 Lakh
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹19,400 ₹50,000 ₹88,300 ₹4.72 Lakh
Purchases of Stock-in-Trade ₹0 ₹48.56 Lakh ₹0 ₹1.58 Cr ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 -₹28.42 Lakh ₹0 ₹0 ₹0 ₹7.66 Lakh -₹7.66 Lakh ₹0
Employee Benefit Expense ₹10.59 Lakh ₹12.09 Lakh ₹3.75 Lakh ₹14.96 Lakh ₹13.99 Lakh ₹8.58 Lakh ₹17.65 Lakh ₹26.69 Lakh
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹4.26 Lakh ₹17.75 Lakh ₹17.99 Lakh ₹0
Depreciation & Amortisation ₹37,000 ₹25,000 ₹10,900 ₹79,200 ₹8.41 Lakh ₹18.92 Lakh ₹17.86 Lakh ₹19.37 Lakh
Other Expenses ₹11.79 Lakh ₹8.22 Lakh ₹11.28 Lakh ₹11.07 Lakh ₹30.69 Lakh ₹17.88 Lakh ₹18.77 Lakh ₹25.73 Lakh
Total Expenses ₹22.75 Lakh ₹40.7 Lakh ₹15.14 Lakh ₹1.85 Cr ₹57.54 Lakh ₹71.29 Lakh ₹65.49 Lakh ₹76.51 Lakh
Profit Before Exceptional Items & Tax ₹4 Lakh ₹44.14 Lakh ₹1.52 Lakh ₹91.32 Lakh -₹42.08 Lakh -₹50.19 Lakh ₹20.57 Lakh ₹23.47 Lakh
Exceptional Items ₹0 ₹0 ₹0 -₹26.43 Lakh ₹41.92 Lakh ₹0 ₹0 ₹0
Profit Before Tax ₹4 Lakh ₹44.14 Lakh ₹1.52 Lakh ₹64.89 Lakh -₹16,500 -₹50.19 Lakh ₹20.57 Lakh ₹23.47 Lakh
Total Tax Expense ₹97,000 ₹8.53 Lakh -₹300 ₹6,100 ₹76,900 ₹5.72 Lakh -₹8.03 Lakh ₹22,000
Net Profit ₹3.03 Lakh ₹35.61 Lakh ₹1.52 Lakh ₹64.83 Lakh -₹93,400 -₹55.91 Lakh ₹28.6 Lakh ₹23.25 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹3.03 Lakh ₹35.61 Lakh ₹1.52 Lakh ₹64.83 Lakh -₹93,400 -₹55.91 Lakh ₹28.6 Lakh ₹23.25 Lakh
EBITDA (computed) ₹4.37 Lakh ₹44.39 Lakh ₹1.62 Lakh ₹92.11 Lakh -₹29.41 Lakh -₹13.52 Lakh ₹56.42 Lakh ₹42.84 Lakh
Basic EPS ₹0.10 ₹1.17 ₹0.05 ₹2.12 ₹-0.03 ₹-1.83 ₹0.94 ₹0.76
Diluted EPS ₹0.10 ₹1.17 ₹0.05 ₹2.12 ₹-0.03 ₹-1.83 ₹0.94 ₹0.76
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹4.25 Cr ₹4.36 Cr ₹4.33 Cr ₹4.42 Cr ₹3.8 Cr ₹7.62 Cr ₹8.01 Cr ₹7.18 Cr
Non-current Assets ₹1.55 Cr ₹1.73 Cr ₹1.42 Cr ₹1.84 Cr ₹2.66 Cr ₹7.45 Cr ₹7.6 Cr ₹6.88 Cr
Current Assets ₹2.7 Cr ₹2.62 Cr ₹2.91 Cr ₹2.58 Cr ₹1.14 Cr ₹16.37 Lakh ₹40.44 Lakh ₹30.13 Lakh
Property, Plant & Equipment ₹50,000 ₹87,000 ₹20,600 ₹31,600 ₹1.75 Cr ₹5.86 Cr ₹4.47 Cr ₹4.31 Cr
Inventories ₹28.42 Lakh ₹28.42 Lakh ₹0 ₹0 ₹0 ₹0 ₹12.4 Lakh ₹11.87 Lakh
Trade Receivables ₹2.32 Cr ₹2.21 Cr ₹2.53 Cr ₹2.22 Cr ₹0 ₹6.49 Lakh ₹10.27 Lakh ₹5.83 Lakh
Cash & Equivalents ₹44,000 ₹2.29 Lakh ₹22,900 ₹0 ₹0 ₹0 ₹3.19 Lakh ₹31,000
Equity (Net Worth) ₹3.93 Cr ₹3.9 Cr ₹3.54 Cr ₹3.53 Cr ₹2.88 Cr ₹4.49 Cr ₹5.05 Cr ₹4.76 Cr
Equity Share Capital ₹3.05 Cr ₹3.05 Cr ₹3.05 Cr ₹3.05 Cr ₹3.05 Cr ₹3.05 Cr ₹3.05 Cr ₹3.05 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹1.55 Cr ₹1.48 Cr ₹1.48 Cr
Borrowings (Current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Debt (computed) ₹0 ₹0 ₹0 ₹0 ₹0 ₹1.55 Cr ₹1.48 Cr ₹1.48 Cr
Current Liabilities ₹32.08 Lakh ₹45.79 Lakh ₹79.14 Lakh ₹89.33 Lakh ₹21.43 Lakh ₹87.13 Lakh ₹76.85 Lakh ₹7.28 Lakh
Total Liabilities ₹32.11 Lakh ₹45.84 Lakh ₹79.16 Lakh ₹89.35 Lakh ₹91.88 Lakh ₹3.13 Cr ₹2.96 Cr ₹2.42 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹1.9 Lakh ₹2.72 Lakh -₹2.01 Lakh -₹1.04 Cr -₹2.13 Cr
Investing Cash Flow ₹0 ₹1.19 Lakh -₹1.52 Lakh ₹1.79 Cr ₹3.67 Cr
Financing Cash Flow ₹0 ₹0 ₹0 -₹70.45 Lakh -₹1.55 Cr
Capital Expenditure ₹0 ₹91,000 ₹0 ₹0 ₹0
Free Cash Flow (computed) -₹1.9 Lakh ₹1.81 Lakh -₹2.01 Lakh -₹1.04 Cr -₹2.13 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹1.9 Lakh ₹4.52 Lakh -₹3.52 Lakh ₹3.86 Lakh -₹87,700
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹3.75 Lakh ₹5 Lakh ₹9 Lakh ₹9 Lakh ₹26.35 Lakh ₹22.01 Lakh ₹20.5 Lakh ₹15.53 Lakh
Other Income ₹0 ₹0 ₹0 ₹0 ₹1,000 ₹4,300 ₹72,000 ₹0
Total Income ₹3.75 Lakh ₹5 Lakh ₹9 Lakh ₹9 Lakh ₹26.36 Lakh ₹22.05 Lakh ₹21.22 Lakh ₹15.53 Lakh
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹48.56 Lakh ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 -₹28.42 Lakh ₹0 ₹0 ₹0
Employee Benefit Expense ₹45,000 ₹2.25 Lakh ₹3.75 Lakh ₹4.14 Lakh ₹4.14 Lakh ₹3.21 Lakh ₹3.54 Lakh ₹1.2 Lakh
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹13,000 ₹8,000 ₹8,000 ₹8,000 ₹10,000 ₹5,000 ₹10,000 ₹0
Other Expenses ₹3.01 Lakh ₹1.62 Lakh ₹4.84 Lakh ₹2.31 Lakh ₹1.79 Lakh ₹3.26 Lakh ₹2.83 Lakh ₹1.57 Lakh
Total Expenses ₹3.59 Lakh ₹3.95 Lakh ₹8.67 Lakh ₹6.53 Lakh ₹26.17 Lakh ₹6.52 Lakh ₹6.47 Lakh ₹2.77 Lakh
Profit Before Exceptional Items & Tax ₹16,000 ₹1.05 Lakh ₹33,000 ₹2.47 Lakh ₹19,000 ₹15.54 Lakh ₹14.76 Lakh ₹12.76 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹16,000 ₹1.05 Lakh ₹33,000 ₹2.47 Lakh ₹19,000 ₹15.54 Lakh ₹14.76 Lakh ₹12.76 Lakh
Total Tax Expense ₹97,000 ₹0 ₹0 ₹0 ₹8.53 Lakh ₹0 ₹0 ₹0
Net Profit -₹81,000 ₹1.05 Lakh ₹33,000 ₹2.47 Lakh -₹8.34 Lakh ₹15.54 Lakh ₹14.76 Lakh ₹12.76 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹81,000 ₹1.05 Lakh ₹33,000 ₹2.47 Lakh -₹8.34 Lakh ₹15.54 Lakh ₹14.76 Lakh ₹12.76 Lakh
EBITDA (computed) ₹29,000 ₹1.13 Lakh ₹41,000 ₹2.55 Lakh ₹29,000 ₹15.59 Lakh ₹14.86 Lakh ₹12.76 Lakh
Basic EPS ₹-0.03 ₹0.03 ₹0.01 ₹0.08 ₹-0.27 ₹0.51 ₹0.48 ₹0.42
Diluted EPS ₹-0.03 ₹0.03 ₹0.01 ₹0.08 ₹-0.27 ₹0.51 ₹0.48 ₹0.42
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Genomic Valley Biotech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Charges & Borrowings of Genomic Valley Biotech Limited

Open charges
₹0
Satisfied charges
₹3.74 Cr
Breakdown by lending institutions
Others₹3.74 Cr
Latest charge details
DateLenderAmountStatus
27 Apr 2021 Others ₹2.26 Cr Satisfied
30 Apr 2019 Others ₹1.48 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Genomic Valley Biotech Limited

View historical data on people associated with Genomic Valley Biotech Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Genomic Valley Biotech Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Genomic Valley Biotech Limited

Premium access

GST registrations and filing compliance for Genomic Valley Biotech Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Genomic Valley Biotech Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Genomic Valley Biotech Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Genomic Valley Biotech Limited

Premium access

MSME payment history for Genomic Valley Biotech Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Genomic Valley Biotech Limited

Premium access

Corporate group structure for Genomic Valley Biotech Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Genomic Valley Biotech Limited

Premium access

MCA filings and documents for Genomic Valley Biotech Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Genomic Valley Biotech Limited

Activity
31 Dec 2025
Genomic Valley Biotech Limited last Annual general meeting of members was held on 31 Dec 2025 as per latest MCA records.
Directors
30 May 2025
Yogainder Kumar Gupta was appointed as a Director on 30 May 2025 & has been associated with this company since 1 year 1 month.
Activity
31 Mar 2025
Genomic Valley Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Directors
09 May 2024
Satendra Kumar Goyal was appointed as a Director on 09 May 2024 & has been associated with this company since 2 years 2 months.
Directors
14 Feb 2024
Parul Agrawal was appointed as a Director on 14 Feb 2024 & has been associated with this company since 2 years 5 months.
Directors
14 Nov 2023
Ashok Kumar was appointed as a Additional Director on 14 Nov 2023 & has been associated with this company since 2 years 8 months.

Frequently Asked Questions about Genomic Valley Biotech Limited

Genomic Valley Biotech Limited is an active public limited company in the life sciences sector based in Jhajjar, Haryana, India. It was incorporated on 16 May 1994 (32+ years old) and is registered under CIN L01122HR1994PLC033029. Listed on BSE: 539206.

Genomic Valley Biotech Limited reported revenue of ₹26.75 Lakh for FY 2026 (down 68.3% YoY) based on standalone BSE filings.

The current directors of Genomic Valley Biotech Limited are:

The primary industry of Genomic Valley Biotech Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Yes. Genomic Valley Biotech Limited is listed on BSE with code 539206.

Genomic Valley Biotech Limited can be reached at the registered office: 4 K.M.Stone Berri Chharra Road Vill. Kherka Musalman P.O.Tandaheri Teh Bahadu, Jhajjar, Haryana, India – 124507, or through the website genomicvalley.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available